28 April 2021>: Articles
Glycemic Profile of Intravenous Dexamethasone-Induced Hyperglycemia Using Continuous Glucose Monitoring
Unusual clinical course, Unusual or unexpected effect of treatment, Educational Purpose (only if useful for a systematic review or synthesis)
Fan Zhang A* , Jocelyne G. Karam ADOI: 10.12659/AJCR.930733
Am J Case Rep 2021; 22:e930733
Figure 2. The 10 days CGM glycemia profile of 23 cycles following chemotherapy which contained one dose of IV Dexamethasone (arrow). It demonstrated a triphasic glycemic pattern gradually returns to baseline after 3 days. (Lighter lines are standard deviation) (* Normal glucose phase between 2 hyperglycemia phases; ** hyperglycemia plateau shape similar to the baseline.)